The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through ‘stacking’ of drugs from different classes

Documenti analoghi

• Diabetic Charcot neuroarthropathy: A threat to both limb and life
  di: David S. H. Bell, et al.
  Pubblicazione: (2024)
• Diabetic distal symmetric polyneuropathy: More than just “tingling in the feet”
  di: David S. H. Bell, et al.
  Pubblicazione: (2025)
• Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium‐glucose cotransporter‐2 inhibitor and glucagon‐like peptide ‐1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease
  di: Shunichiro Tsukamoto, et al.
  Pubblicazione: (2024)
• Impact of non‐alcoholic fatty liver disease and fibrosis on mortality and kidney outcomes in patients with type 2 diabetes and chronic kidney disease: A multi‐cohort longitudinal study
  di: Lijun Zhao, et al.
  Pubblicazione: (2024)
• Effect of semaglutide on primary prevention of diabetic kidney disease in people with type 2 diabetes: A post hoc analysis of the SUSTAIN 6 randomized controlled trial
  di: Jingyu Wang, et al.
  Pubblicazione: (2024)